Surgical Infection Prevention: Success Stories
NEW YORK
IPRO, Medicare’s Quality Improvement Organization for New York
conducted a statewide voluntary Surgical Infection Prevention Collaborative
with 22 hospitals; below is a description of one hospital’s success:
Glen Cove Hospital Achieves Dramatic Improvement on SIP Measures
Glen Cove
Hospital, part of the 15-hospital North Shore-Long Island Jewish Health
System, enthusiastically participated in IPRO’s voluntary
Surgical Infection Prevention (SIP) Collaborative, which ran from July
2003 through March 2004. The objective of this collaborative was to reduce
surgical infections by improving the selection and timing of prophylactic
antibiotics. Glen Cove started out with an excellent rate of appropriate
selection of antibiotics, so they focused mostly on the timing issues.
They targeted their efforts initially on their primary hip and knee arthroplasty
patients, intending to spread improvements throughout their institution
once established in this population.
Team members came together from many different departments, including
surgery, pharmacy, infection control, and quality management. Of great
importance was the active involvement of the leadership in several departments,
including Dr. David Berger, Chairman of Anesthesia, Dr. Eugene Krauss,
Chairman of Orthopedics, the Director of Perioperative Services, the
Director and Assistant Director of Pharmacy, and the Manager of their
Total Joint Program.
The team used a series of Plan, Do, Study, Act (PDSA) cycles to plan
out their strategy. Thanks to the involvement of senior administration
and clinical directors, improvements came rapidly. A previous policy,
which stipulated that pre-operative antibiotic was to be given in the
holding area, was changed so it could now be given in the OR. The pharmacy
researched the availability of ready-mix Cefazolin to facilitate its
administration and the anesthesia department accepted the primary role
for antibiotic pre-operative administration. An almost immediate improvement
in the timing of the first dose of antibiotic was measured, with the
performance improving from a baseline rate of 46% in July 2003, to over
90% by September 2003, and reaching 100% by January 2004 where it stayed
until the end of the collaborative.
The team
also focused on the other challenging performance measurement, namely
discontinuing antibiotic prophylaxis within 24 hours of the end of
surgery. During the fall, meetings were held with the surgeons to discuss
the length of postoperative antibiotics and infection control also
started to monitor post-op antibiotics. Shortly after, a meeting between
the division leaders resulted in the development of a new protocol
for timely discontinuance of prophylactic antibiotics that was presented
to both QA and P&T
Committees. Finally, the changes were finalized and written into the
pre-op sheet, pre-printed orders, care maps, and the OR tracking tool.
Very rapid improvements were noted in the performance measure, which
rose from under 50% in the fall of 2003 to 100% by the beginning of
2004.
The team is strongly dedicated to building on the progressive momentum
that they have started through this collaboration; by the middle of 2004
they had already begun to examine and track colon surgeries for these
same performance measures.
The Collaborative
was led by IPRO, the Medicare Quality Improvement Organization for
New York, under contract with the Centers for Medicare & Medicaid
Services (CMS), an agency of the U.S. Department of Health and Human
Services. IPRO is continuing to work with hospitals statewide to improve
quality of care and to continue to decrease their rates of surgical infection.
For more
information about IPRO’s quality improvement resources
for surgical infection prevention, contact Dr. Charles Stimler, (516)
326-7767, ext. 634, email Cstimler@nyqio.sdps.org or
Sheila McCullagh, Director, Consumer Protection & Outreach, (516)
326-7767 ext 619 or Smccullagh@nyqio.sdps.org
This material
was prepared by IPRO, the Medicare Quality Improvement Organization
for NewYork, under contract with the Centers for Medicare & Medicaid
Services (CMS), an agency of the U.S. Department of Health and Human
Services. The contents do not necessarily reflect CMS policy.
|